The mode of action of Shiga toxin in bacterial pathogensis is to be explored at the whole cell and subcellular levels. The mechanism of our newly discovered latent cytotoxicity effect exhibited by Shiga toxin on human vascular endothelial cells in culture is to be investigated in regard to the temporal relationship of toxin binding and entry into these cells. A role for this in vitro latent cytotoxicity phenomenon will be explored to help explain a similar latent effect of Shiga toxin in human vascular diseases such as hemorrhagic colitis and hemolytic uremic syndome. At the subcellular level, three different molecular approaches are described to reveal how Shiga toxin enzymatically inactivates mammalian ribosomes, the primary target of this toxin which is responsible for inhibition of protein synthesis and Shiga-related cytotoxicity. First, emphasis is placed on our efforts to define the ribonuclease activity which continues to appear to be an inherent property of purified Shiga toxin. Shiga RNase activity is to be studied using the intact ribosome, highly purified rRNA and RNA homopolymer substrates. Second, to more fully answer the question of how Shiga toxin recognizes and interacts with eukaryotic ribosomes, we present a research plan based on hybridzation of defined cloned rRNA gene fragments to intact ribosomes to protect the ribosome against inactivation by Shiga toxin. This experimental approach will help reveal which rRNA regions are required for Shiga toxin recognition of ribosomes. Third, (125I)Shiga toxin will be covalently crosslinked to its natural ribosomal binding site using a photoaffinity reagent. A research plan is described for identification of those ribosomal protein and rRNA species located within the toxin binding site to which Shiga toxin becomes crosslinked. Together, these molecular studies would provide a description of how Shiga toxin identifies and catalytically inactivates mammalian ribosomes. In addition, the endothelial cellular investigations should yield new information about Shiga toxin cytotoxic mechanisms in clinically- related vascular diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Unknown (R22)
Project #
5R22AI024431-03
Application #
3565501
Study Section
Bacteriology and Mycology Subcommittee 1 (BM)
Project Start
1987-03-01
Project End
1990-02-28
Budget Start
1989-03-01
Budget End
1990-02-28
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Albany Medical College
Department
Type
DUNS #
City
Albany
State
NY
Country
United States
Zip Code
12208
Obrig, Tom G; Karpman, Diana (2012) Shiga toxin pathogenesis: kidney complications and renal failure. Curr Top Microbiol Immunol 357:105-36
Fujii, Jun; Naito, Mariko; Yutsudo, Takashi et al. (2012) Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice. Clin Vaccine Immunol 19:1932-7
Psotka, Mitchell A; Obata, Fumiko; Kolling, Glynis L et al. (2009) Shiga toxin 2 targets the murine renal collecting duct epithelium. Infect Immun 77:959-69
Kolling, Glynis L; Obata, Fumiko; Gross, Lisa K et al. (2008) Immunohistologic techniques for detecting the glycolipid Gb(3) in the mouse kidney and nervous system. Histochem Cell Biol 130:157-64
Stone, Matthew K; Kolling, Glynis L; Lindner, Matthew H et al. (2008) p38 mitogen-activated protein kinase mediates lipopolysaccharide and tumor necrosis factor alpha induction of shiga toxin 2 sensitivity in human umbilical vein endothelial cells. Infect Immun 76:1115-21
Keepers, Tiffany R; Gross, Lisa K; Obrig, Tom G (2007) Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome. Infect Immun 75:1229-36
Keepers, Tiffany R; Psotka, Mitchell A; Gross, Lisa K et al. (2006) A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J Am Soc Nephrol 17:3404-14
Guessous, Fadila; Marcinkiewicz, Marek; Polanowska-Grabowska, Renata et al. (2005) Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function. Infect Immun 73:8306-16
Guessous, Fadila; Marcinkiewicz, Marek; Polanowska-Grabowska, Renata et al. (2005) Shiga toxin 2 and lipopolysaccharide cause monocytic THP-1 cells to release factors which activate platelet function. Thromb Haemost 94:1019-27
Fujii, Jun; Matsui, Takashi; Heatherly, Daniel P et al. (2003) Rapid apoptosis induced by Shiga toxin in HeLa cells. Infect Immun 71:2724-35

Showing the most recent 10 out of 23 publications